Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

William Blair Downgrades DermTech to Market Perform

William Blair analyst Brian Weinstein downgrades DermTech (NASDAQ:DMTK) from Outperform to Market Perform.

byBenzinga Newsdesk

November 4, 2022

1 minute read

William Blair analyst Brian Weinstein downgrades DermTech (NASDAQ:DMTK) from Outperform to Market Perform.

JMP Securities Maintains Market Outperform on Axon Enterprise, Raises Price Target to $235

By Benzinga Newsdesk

Today, 3:33 PM

JMP Securities analyst Erik Suppiger maintains Axon Enterprise (NASDAQ:AXON) with a Market Outperform and raises the price target from $195 to $235.

AXON

Wendy’s, Tiger Pistol Partnership Sets The New Standard For Collaborative Advertising In The QSR Industry

By Benzinga Newsdesk

Today, 3:33 PM

Tiger Pistol, the leading collaborative advertising platform that delivers local activation at scale, announced today a partnership with The Wendy's Company, the global quick service restaurant, to power its

WEN

Credit Suisse Initiates Coverage On Essex Property Trust with Underperform Rating, Announces Price Target of $247

By Benzinga Newsdesk

Today, 3:33 PM

Credit Suisse analyst Tayo Okusanya initiates coverage on Essex Property Trust (NYSE:ESS) with a Underperform rating and announces Price Target of $247.

ESS